NS-2710

NS-2710 is a drug that was developed by NeuroSearch. It acts as a potent and selective dopamine reuptake inhibitor, with a Ki of 12.7nM at the DAT, but no significant affinity for the NET or SERT. This profile of activity is similar to that of GBR-12909, but NS-2710 is much more potent in comparison.

Pharmacology

NS-2710 is a potent and selective dopamine reuptake inhibitor. It has a Ki of 12.7nM at the DAT, but no significant affinity for the NET or SERT. This profile of activity is similar to that of GBR-12909, but NS-2710 is much more potent in comparison.

Development

NS-2710 was developed by NeuroSearch, a Danish pharmaceutical company that specializes in the development of drugs for neurological disorders. The development of NS-2710 was part of the company's efforts to develop new treatments for Parkinson's disease and other dopaminergic disorders.

See also

• Dopamine transporter
• NeuroSearch
• Vanoxerine

NS-2710 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski